Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Maytal Shabat-SimonAbraham Zangen

Abstract

The rewarding effects of drugs of abuse are thought to be dependent on the mesocorticolimbic dopamine system, which originates in the ventral tegmental area (VTA) and projects into the nucleus accumbens (NAC) and other forebrain regions. Heroin, by inhibiting GABAergic interneurons in the VTA, induces local dopaminergic activation and release in the NAC terminals. The role of other basic neurotransmitter systems, such as glutamate in the VTA, in mediating the rewarding effect of addictive drugs, is less established. We explored whether blockade of glutamate receptors in subregions of the VTA modulate the rewarding properties and/or the development of psychomotor changes induced by opiates. Administration of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; an AMPA/kainate receptor antagonist) into the anterior VTA blocked the rewarding effects of opiates in both the conditioned place preference and the self-administration paradigms without affecting the gradual increase of the psychomotor response to opiates. In contrast, administration of CNQX into the posterior VTA did not affect the rewarding properties of opiates, but blocked the initial sedative effect of opiates and the gradual increase of the psychomotor response to the drug. ...Continue Reading

Citations

Feb 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rubing Zhao-SheaAndrew R Tapper
Sep 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bin WangRoy A Wise
May 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·James L GoodsonJames D Klatt
Jun 19, 2010·Brain : a Journal of Neurology·Jaymin UpadhyayDavid Borsook
Feb 22, 2012·Addiction Biology·Shannon L ColeShoshana Eitan
Oct 30, 2008·The Journal of Pharmacology and Experimental Therapeutics·Johanna J BogulavskyCharles E Inturrisi
Jul 30, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Linzy M HendricksonAndrew R Tapper
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michel BarrotThomas C Jhou
Jul 16, 2010·Expert Opinion on Investigational Drugs·Marta Rodríguez-AriasJosé Miñarro
Dec 29, 2012·Brain Research·Jesse M S Ellis, Lauren V Riters
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence
Oct 2, 2009·Peptides·Richard J Bodnar
Apr 9, 2009·Pharmacology, Biochemistry, and Behavior·Vigdis VindenesJørg Mørland
Nov 26, 2015·Frontiers in Neuroscience·Manoranjan S D'Souza
Jan 29, 2013·The European Journal of Neuroscience·Laurie SellingsDerek van der Kooy
Nov 4, 2009·Journal of Neuroscience Research·Natalia Omelchenko, Susan R Sesack
Sep 23, 2014·Neuroscience·M J Sanchez-CatalanM Barrot
Dec 22, 2010·European Journal of Pharmacology·Carmen ManzanedoMarta Rodríguez-Arias
Jun 28, 2018·Canadian Journal of Physiology and Pharmacology·Fateme AboutalebiMaryam Radahmadi
Feb 23, 2019·Addiction Biology·Anne Marte Sjursen KvelloInger Lise Bogen
Feb 24, 2019·Psychopharmacology·Francis Rodriguez BambicoJosé N Nobrega
Apr 29, 2020·Cold Spring Harbor Perspectives in Medicine·Jasper A HeinsbroekJamie Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.